560 related articles for article (PubMed ID: 9864259)
1. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
2. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
[TBL] [Abstract][Full Text] [Related]
3. Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
Tryoen-Tóth P; Décaillot FM; Filliol D; Befort K; Lazarus LH; Schiller PW; Schmidhammer H; Kieffer BL
J Pharmacol Exp Ther; 2005 Apr; 313(1):410-21. PubMed ID: 15590769
[TBL] [Abstract][Full Text] [Related]
4. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
[TBL] [Abstract][Full Text] [Related]
5. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
7. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
Negus SS; Butelman ER; Chang KJ; DeCosta B; Winger G; Woods JH
J Pharmacol Exp Ther; 1994 Sep; 270(3):1025-34. PubMed ID: 7932149
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
10. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
Liu JG; Prather PL
J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
[TBL] [Abstract][Full Text] [Related]
11. Spinal delta-opioid receptors mediate suppression of systemic SNC80 on excitability of the flexor reflex in normal and inflamed rat.
Cao CQ; Hong Y; Dray A; Perkins M
Eur J Pharmacol; 2001 Apr; 418(1-2):79-87. PubMed ID: 11334868
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
13. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
15. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
16. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
[TBL] [Abstract][Full Text] [Related]
17. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
18. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
19. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
Crook TJ; Kitchen I; Hill RG
Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
[TBL] [Abstract][Full Text] [Related]
20. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
